{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:08:50Z","timestamp":1789204130718,"version":"build-2803163510"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089985","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T16:51:27Z","timestamp":1393606287000},"page":"e89985","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":83,"title":["Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan"],"prefix":"10.1371","volume":"9","author":[{"given":"Linda","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Scandinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae R.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"O Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"RC Kessler","year":"2003","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0006-3223(02)01405-1","article-title":"Preclinical models: status of basic research in depression","volume":"52","author":"EJ Nestler","year":"2002","journal-title":"Biol Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed pharmacological effects of antidepressants","volume":"7","author":"A Frazer","year":"2002","journal-title":"Mol Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.mehy.2012.02.012","article-title":"An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan","volume":"78","author":"EC Lauterbach","year":"2012","journal-title":"Med Hypotheses"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"CA Zarate Jr","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"RM Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"RB Price","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.06.013","article-title":"A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder","volume":"207","author":"LL Werling","year":"2007","journal-title":"Exp Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2010.04.003","article-title":"Sigma receptors: potential targets for a new class of antidepressant drug","volume":"127","author":"JA Fishback","year":"2010","journal-title":"Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/clpt.1985.235","article-title":"Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation","volume":"38","author":"B Schmid","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0091270004269521","article-title":"Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers","volume":"44","author":"LE Pope","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/NRL.0b013e3180f60bd8","article-title":"Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action","volume":"13","author":"LL Werling","year":"2007","journal-title":"Neurologist"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"T Hayashi","year":"2007","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"TP Su","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbr.2008.11.036","article-title":"Sigma-1 receptor knockout mice display a depressive-like phenotype","volume":"198","author":"V Sabino","year":"2009","journal-title":"Behav Brain Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(96)00497-9","article-title":"Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test","volume":"312","author":"K Matsuno","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0091-3057(98)00093-8","article-title":"Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension","volume":"61","author":"M Ukai","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"ref19","first-page":"923","article-title":"Potential antidepressant activity of sigma ligands","volume":"55","author":"G Skuza","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00008877-200211000-00003","article-title":"A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist","volume":"13","author":"G Skuza","year":"2002","journal-title":"Behav Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.euroneuro.2007.02.007","article-title":"Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice","volume":"17","author":"J Wang","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1055\/s-2004-832680","article-title":"Clinical trials with sigma ligands","volume":"37","author":"HP Volz","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728222.12.1.45","article-title":"An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand","volume":"12","author":"T Hayashi","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjp.0704294","article-title":"Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands","volume":"134","author":"JE Bermack","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S1461145708008547","article-title":"Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies","volume":"11","author":"G Lucas","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.euroneuro.2011.08.002","article-title":"Evaluation of sigma (sigma) receptors in the antidepressant-like effects of ketamine in vitro and in vivo","volume":"22","author":"MJ Robson","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpba.2012.07.023","article-title":"A 96-well filtration method for radioligand binding analysis of sigma receptor ligands","volume":"71","author":"JA Fishback","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0006-8993(99)01125-7","article-title":"Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan","volume":"821","author":"YC Chou","year":"1999","journal-title":"Brain Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modelling human depression and anxiety","volume":"4","author":"JF Cryan","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.pbb.2006.06.005","article-title":"Animal models of depression in drug discovery: a historical perspective","volume":"84","author":"R McArthur","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuropharm.2005.04.016","article-title":"Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies","volume":"49","author":"EC Nguyen","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(24)29502-1","article-title":"The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test","volume":"298","author":"A Urani","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S1461145701002760","article-title":"Effects of sigma ligands on NMDA receptor function in the bulbectomy model of depression: a behavioural study in the rat","volume":"5","author":"J Bermack","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuint.2012.01.025","article-title":"Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of sigma-1 receptors","volume":"61","author":"Y Nam","year":"2012","journal-title":"Neurochem Int"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"28198","DOI":"10.1074\/jbc.M802099200","article-title":"Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells","volume":"283","author":"Z Wu","year":"2008","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-5793(99)00084-8","article-title":"Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding","volume":"445","author":"H Yamamoto","year":"1999","journal-title":"FEBS Lett"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/syn.20103","article-title":"Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain","volume":"55","author":"EJ Cobos","year":"2005","journal-title":"Synapse"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-3565(25)10630-7","article-title":"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception","volume":"274","author":"EE Codd","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"JF Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"MJ Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"FP Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0960-894X(01)00023-3","article-title":"Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene","volume":"11","author":"SP Runyon","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"M Tatsumi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain","volume":"307","author":"N Narita","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","article-title":"The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action","volume":"166","author":"PH Andersen","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF02244985","article-title":"Binding of antidepressants to human brain receptors: focus on newer generation compounds","volume":"114","author":"B Cusack","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/0006-2952(93)90211-E","article-title":"Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics","volume":"45","author":"T Stanton","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(25)33153-8","article-title":"A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain","volume":"222","author":"DT Wong","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1073\/pnas.75.12.6290","article-title":"Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine","volume":"75","author":"VT Tran","year":"1978","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T19:31:23Z","timestamp":1746127883000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089985"}},"subtitle":[],"editor":[{"given":"Allan","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089985","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}